Volume 68, Issue 5, Pages (May 2018)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 54, Issue 1, Pages (January 2011)
Volume 63, Issue 1, Pages (July 2015)
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 46, Issue 3, Pages (March 2007)
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Novel insights in the interplay between inflammation and metabolic diseases: A role for the pathogen sensing kinase PKR  Nicolas Marsollier, Pascal Ferré,
Volume 51, Issue 6, Pages (December 2009)
Reactive oxygen species in the normal and acutely injured liver
Obesity, inflammation, and liver cancer
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C
Non-invasive diagnosis of non-alcoholic fatty liver disease
Fructokinase activity mediates dehydration-induced renal injury
Immigration and viral hepatitis
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
Volume 66, Issue 1, Pages 1-4 (January 2017)
Living donor liver transplantation: is the hype over?
Effect of pioglitazone on biochemical indices of non-alcoholic fatty liver disease in upper body obesity  Samyah Shadid, Michael D Jensen  Clinical Gastroenterology.
Volume 55, Issue 4, Pages (October 2011)
Mesenchymal stromal cell therapy for liver diseases
Volume 69, Issue 2, Pages (August 2018)
Stephen A. Harrison, MD, FACP  Clinical Gastroenterology and Hepatology 
European Association for the Study of the Liver  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Sugar, Sugar Not So Sweet for the Liver
Amalia Gastaldelli, Giulio Marchesini  Journal of Hepatology 
Volume 70, Issue 1, Pages (January 2019)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 61, Issue 3, Pages (September 2014)
Volume 54, Issue 5, Pages (May 2011)
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Genomic risk of hepatitis C-related hepatocellular carcinoma
Autophagy in the liver Journal of Hepatology
Volume 59, Issue 3, Pages (September 2013)
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Volume 70, Issue 1, Pages (January 2019)
Volume 57, Issue 5, Pages (November 2012)
Volume 50, Issue 4, Pages (April 2009)
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
AGA technical review on nonalcoholic fatty liver disease
Non-invasive diagnosis and biomarkers in alcohol-related liver disease
Paul C. Adams, James C. Barton  Journal of Hepatology 
NASH animal models: Are we there yet?
Chetana Lim, Chady Salloum, Daniel Azoulay
Immigration and viral hepatitis
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
Global burden of alcoholic liver diseases
Volume 64, Issue 6, Pages (June 2016)
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
The use of hemospray in portal hypertensive bleeding; a case series
Volume 62, Issue 3, Pages (March 2015)
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Inflammatory pathways in alcoholic steatohepatitis
Chimeric mouse model of hepatitis B virus infection
A 360-degree overview of paediatric NAFLD: Recent insights
Genetics of hepatocellular carcinoma: The next generation
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Volume 135, Issue 6, Pages (December 2008)
Presentation transcript:

Volume 68, Issue 5, Pages 1063-1075 (May 2018) Fructose and sugar: A major mediator of non-alcoholic fatty liver disease  Thomas Jensen, Manal F. Abdelmalek, Shelby Sullivan, Kristen J. Nadeau, Melanie Green, Carlos Roncal, Takahiko Nakagawa, Masanari Kuwabara, Yuka Sato, Duk-Hee Kang, Dean R. Tolan, Laura G. Sanchez-Lozada, Hugo R. Rosen, Miguel A. Lanaspa, Anna Mae Diehl, Richard J. Johnson  Journal of Hepatology  Volume 68, Issue 5, Pages 1063-1075 (May 2018) DOI: 10.1016/j.jhep.2018.01.019 Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Association of added sugar consumption with rates of NAFLD, obesity in NHANES data. NAFLD, non-alcoholic fatty liver disease; NHANES, National Health and Nutrition Examination Survey. Journal of Hepatology 2018 68, 1063-1075DOI: (10.1016/j.jhep.2018.01.019) Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Interaction of fructose, glucose and polyol pathway with uric acid and triglycerides. Journal of Hepatology 2018 68, 1063-1075DOI: (10.1016/j.jhep.2018.01.019) Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Fructose mechanism mediating development and progression of NAFLD. DNL, de novo lipogenesis; ER, endoplasmic reticulum; KHK-C, ketohexokinase-C; NAFLD, non-alcoholic fatty liver disease. Journal of Hepatology 2018 68, 1063-1075DOI: (10.1016/j.jhep.2018.01.019) Copyright © 2018 European Association for the Study of the Liver Terms and Conditions